On 31th of May, 2021 Oncodia released a scheduled minor update of ALTOmate to version 1.1.0. The new version includes improved sensitivity, enhanced InDel alignment model and adjustments of the reads mapped as singletons. Following a request to report mutations with limited evidence to assure compete sample evaluation, the new version introduced a low evidence category of calls. ALTOmate v.1.1.0 will not compromise the high selectivity and at the same time will substantially reduce the possibility for a missed somatic mutation.
The release notes can be found in the following link:
ALTOmate v1.1.0 Release Notes.
We are always happy to hear the feedback and comments of our customers, so please do not hesitate to contact us with any questions concerning the new software version.